Journal Logo

Poster Session II: Chronic myeloid leukemia – Clinical

PS1190 R-INTERFERON TREATMENT BEFORE TKI START IMPROVES TREATMENT FREE REMISSION RATE (TFR) PARTICULARLY IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WITH THE LESS FAVORABLE E13A2 BCR-ABL1 TRANSCRIPT TYPE

D’Adda, M.1; Farina, M.1; Passi, A.1; Gramegna, D.1; Daffini, R.1; Ferrari, S.1; Bottelli, C.1; Borlenghi, E.1; Cerqui, E.1; Bertoli, D.2; Archetti, S.2; Marini, M.3; Rossi, G.1

Author Information
doi: 10.1097/01.HS9.0000563044.98383.6f
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.